Veracyte (VCYT) Non-Current Deferred Tax Liability (2014 - 2026)
Veracyte (VCYT) posted quarterly Non-Current Deferred Tax Liability of $637000.0 for Q2 2026, down 51.04% year-over-year from $1.3 million in Q2 2025, and little changed on a QoQ basis from $636000.0 in Q1 2026.
Veracyte (VCYT) Non-Current Deferred Tax Liability (2014 - 2026) Analysis & Trends
Veracyte has reported Non-Current Deferred Tax Liability for 10 years, with the latest figure at $637000.0 in Q2 2026.
- Non-Current Deferred Tax Liability for Q2 2026 came in at $637000.0, down 51.04% year-over-year; the trailing twelve-month figure through Jun 2026 was $637000.0 (down 51.04% YoY), and the FY2025 annual result was $646000.0, down 98.17% from the prior year.
- Non-Current Deferred Tax Liability held at $637000.0 in Q2 2026, from $636000.0 in the prior quarter.
- Over five years, Non-Current Deferred Tax Liability peaked at $36.7 million in Q4 2022 and troughed at $636000.0 in Q1 2026.
- A 5-year average of $7.4 million and a median of $2.6 million in 2023 frame the typical range for Non-Current Deferred Tax Liability.
- The widest annual swing landed in 2022, when Non-Current Deferred Tax Liability jumped 564.4%; it then plunged 98.17% in 2025.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $36.7 million in 2022, then tumbled by 35.65% to $23.6 million in 2023, then surged by 48.89% to $35.2 million in 2024, then sank by 98.17% to $646000.0 in 2025, then retreated by 1.39% to $637000.0 in 2026.
- Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $637000.0 in Q2 2026, $636000.0 in Q1 2026, and $646000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Veracyte | 3.62 Bn | 3.32 Bn | 108.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 637,000.00 |
| Jun 30, 2026 | 637,000.00 |
| Mar 31, 2026 | 636,000.00 |
| Mar 31, 2026 | 636,000.00 |
| Dec 31, 2025 | 646,000.00 |
| Dec 31, 2025 | 646,000.00 |
| Sep 30, 2025 | 1.21 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Mar 31, 2025 | 1.24 Mn |
| Dec 31, 2024 | 35.21 Mn |
| Dec 31, 2024 | 35.21 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Sep 30, 2024 | 1.47 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Jun 30, 2024 | 1.48 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Mar 31, 2024 | 1.34 Mn |